INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹442 Cr | ₹508 Cr | ₹130 Cr | ₹297 Cr | ₹172 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDEGENE ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹442 Cr |
Mar2024 | ₹508 Cr |
Mar2023 | ₹130 Cr |
Mar2022 | ₹297 Cr |
Mar2021 | ₹172 Cr |
How is Cash Flow from Operating Activities of INDEGENE Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹442 Cr | -12.96 | |
Mar2024 | ₹508 Cr | 289.94 | |
Mar2023 | ₹130 Cr | -56.17 | |
Mar2022 | ₹297 Cr | 72.67 | |
Mar2021 | ₹172 Cr | - |
Compare Cash Flow from Operating Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,786.5 Cr | 1.9% | 0.2% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 1.9% |
0.2% |
0.8% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses